Delivery Order SPE2DB24D1205-SPE2DB25FDAGT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials valued at $1,157.18 under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,314.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of VYEPTI 100 mg/ml vials. The contract is non-set-aside and competitively awarded, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,785.90 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vial medication, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order, awarded on September 2, 2025, represents a non-competitive set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 MG/ML vial, a pharmaceutical product for federal medical supply needs. Issued on August 27, 2025, with an ultimate completion date of September 18, 2025, this firm fixed-price delivery order represents a non-competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyepti 100 mg/ml vials. This non-set-aside contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Department's Medical Supply Chain awarded a $20,829.24 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of VYEPTI 100 MG/ML vials. The non-competitive delivery order, which is firm fixed price and due for completion by September 29, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,471.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a single delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $57,859.00 delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 MG/ML Vial on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAGTDelivery Order
The Defense Logistics Agency awarded a $9,257.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of VYEPTI 100 mg/ml vial medication. The contract, with an ultimate completion date of September 30, 2025, is non-set-aside and competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, the company delivers specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for VYEPTI represents a routine fulfillment of medical supply needs under this established prime vendor contract framework supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/9/25 |